Dosidal · Canada

FLUORESCEIN

Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.

MarketCanada
Recordca:authorisation:din:02027097:16626 (version 1)
Levelauthorisation
Pack codenot anchored
Identifiersca-din: 02027097
ca-dpd-drug-code: 16626
Source authorityHealth Canada
Read date2026-11-15T06:54:55Z
authorisation statuslifecycle: history
status: CANCELLED POST MARKET
status_date: 2020-06-15
status_date_as_published: 15-JUN-2020
status_history: date: 2017-05-08
status: MARKETED; date: 2017-05-08
status: APPROVED; date: 2018-07-10
status: APPROVED; date: 2018-07-10
status: DORMANT; date: 2018-07-10
status: MARKETED; date: 2020-06-15
status: CANCELLED POST MARKET; date: 2017-07-18
status: DORMANT; date: 1994-12-31
status: MARKETED
state: current · read 2026-11-15T06:54:55Z · source: Health Canada - Drug Product Database page
controlled statuscontrolled: False
state: current · read 2026-11-15T06:54:55Z · source: Health Canada - Drug Product Database page
identityatc: V04CX
brand_name: FLUORESCEIN
class: Human
companies: PHARMA STULLN INC.
din: 02027097
drug_code: 16626
extract_set: cancelled
forms: SOLUTION
ingredients: ingredient: FLUORESCEIN SODIUM
strength: 250 MG
packaging_as_published: product_information: 2ML
routes: INTRAVENOUS
state: current · read 2026-11-15T06:54:55Z · source: Health Canada - Drug Product Database page
prescription classclass: non_prescription (ethical)
schedules: ETHICAL
state: current · read 2026-11-15T06:54:55Z · source: Health Canada - Drug Product Database page
SignatureES256 over JCS, key dosidal-record-1.9dbf5d53
igmBd6wKTLt5tDUUYRlL9IjlP05pPjIxlF_YZ-a7JBe_Yu43_CZCe1U2JyXcoV_4RoRNwKoG2VGcaBAmeTRn9g
Verify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json

JSON: https://dosidal-api.ai/v1/records/ca:authorisation:din:02027097:16626 · Related records in other markets · Dosidal